Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Manufacturing and Supply of Lisinopril Tablets

Active

Federal

Response Deadline09/24/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0032.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Lisinopril Tablets (VA-27-00004937)

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 17

subcontract

Response DeadlineSep 24

Submission deadline

Response Deadline

09/24/2026, 07:30:00 PM UTCin 26 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacturing, packaging, labeling, and delivery of Lisinopril Tablets in multiple strengths (2.5mg, 5mg, 10mg, 20mg, 40mg) compliant with federal pharmaceutical standards and contract requirements.

Similar Contracts

Same NAICS industry code

6505--FY27 SIR-Spheres Y90 Resin Microspheres

Solicitation # 36C24826Q0954

The Department of Veterans Affairs intends to award a sole source, firm-fixed price purchase order to Sirtex Medical Inc. for the procurement of SIR-Spheres Y90 Resin Microspheres and associated accessory kits for the Bay Pines VA Health Care System. The requirement includes ten dose and administration kits, one delivery dome, ten prep sets, and ten delivery sets. This procurement is justified as a sole source action due to the unique, specialized, and proprietary nature of the supplies, which the government believes only Sirtex Medical Inc. can provide. While this notice is not a formal request for competitive proposals, interested parties may submit quotations and evidence of their capability to meet the requirements to determine if a competitive procurement is warranted. All responses must be submitted to the contracting officer, Cindy Smith, by 10 AM Eastern Standard Time on September 14, 2026. If no qualified responses are received, the government will proceed with the sole source acquisition from the identified vendor.

248-NETWORK Contract Office 8 (36C248)

POSTED

DEADLINE

FDA-Approved Radiopharmaceutical Supplies and Cold Kits

Solicitation # HT9406-26-Q-E102

The Defense Health Agency is seeking a contractor to provide all necessary personnel, equipment, and materials for the continuous custom compounding and delivery of FDA-approved radiopharmaceuticals and cold kits. These supplies are to be delivered to the Nuclear Medicine Section at the Dwight David Eisenhower Army Medical Center located at Fort Gordon, Georgia. This combined solicitation, numbered HT9406-26-Q-E102, falls under NAICS code 325412. The response deadline for this opportunity is September 10, 2026, and there are no specific set-aside restrictions applied to this contract.

Defense Health Agency

POSTED

DEADLINE

6505--Droxidopa Capsules (VA-27-00007975)

Solicitation # 36E79726Q0004

The Department of Veterans Affairs is conducting market research to establish a national mandatory requirements contract for Droxidopa Capsules across several federal agencies, including the DoD, IHS, BOP, and FHCC. The procurement covers three strengths of capsules (100mg, 200mg, and 300mg) in 90-count bottles, with a total estimated annual usage of approximately 13,485 bottles. The government seeks a base year with up to four option years and intends to award the contract based on committed volumes to achieve pricing below FSS or Open Market rates. Eligible offerors must possess a unique eleven-digit NDC number and be able to supply products in specific unit of use packaging, featuring child-proof closures and specific bottle dimensions. Non-manufacturers must provide a letter of commitment from their manufacturer, and all contractors must have business-to-business agreements with Pharmaceutical Prime Vendors for distribution. The research also evaluates company size under NAICS code 325412 and compliance with U.S. made or Trade Agreements Act requirements. Responses are due by September 4, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Dextrose Oral Gel (15g, Package of 3's)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Watermelon-Flavored Oral Rehydration Salts

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturer of OTC Sunscreen Preparation (NSN 6505016579247)This subcontract involves the manufacture and supply of an over-the-counter sunscreen preparation for the Department of Defense, specifically the Medical Supply Chain Pharm FSA. The product must strictly adhere to NSN 6505016579247 specifications, requiring a formulation containing 4.5% Titanium Dioxide and 4% Zinc Oxide. All deliverables must include compliant packaging, labeling, and bar-coding as required by the Defense Logistics Agency. The contract falls under NAICS code 325412 and specifies Norfolk, Virginia, as the place of performance. Interested parties must submit their responses by the deadline of September 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE TOPICAL AER

Solicitation # SPE2DP-26-T-4782

This contract is for the procurement of Benzocaine 20 percent oral topical aerosol, provided in 2 fluid ounce containers. The item is regulated by the FDA and is manufactured by Beutlich Pharmaceuticals, LLC. It carries a non-extendable shelf life of 36 months and requires the submission of a Material Safety Data Sheet. Although not officially classified as hazardous, the item must be treated as hazardous material for handling purposes. All shipments must be delivered to the Defense Depot Susquehanna Site East in New Cumberland, Pennsylvania, within 20 days of order. Packaging and marking must strictly adhere to commercial standards and Medical Marking Standard No. 1. The contract specifies a quantity of one unit with a zero percent variance allowed, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DEXTROSE ORAL GEL

Solicitation # SPE2DP-26-T-4781

This contract is for the procurement of Dextrose Oral Gel, specifically 15 gram squeeze tubes with twist-off tips, provided in packages of three. The item is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. All materials must be marked according to Medical Marking Standard No. 1 and packaged in sealed unit containers and commercial exterior shipping containers to ensure safe delivery. The order consists of one package under NSN 6505014253168, with delivery required within 20 days to the USS Zumwalt DDG 1000. Shipping must be handled via the fastest traceable means, specifically avoiding parcel post. The contract specifies that all packaging and palletization must comply with DLA packaging requirements and the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Health Sector Supply Chain Fragility and Investment Prioritization Support Services

Solicitation # 77344426S0002

The U.S. International Development Finance Corporation intends to award a one-year sole source purchase order to the API Innovation Center for specialized technical and analytical support. The objective is to identify and assess vulnerabilities within pharmaceutical and health-sector supply chains to uncover investment and resilience opportunities. The selected contractor will be responsible for producing national fragility analyses, integrating complex datasets regarding manufacturing and geopolitics, and preparing 20 to 30 drug-specific supply chain reports focusing on active pharmaceutical ingredients and upstream dependencies. This procurement action is being conducted under the authority of FAR 13.106-1(b). While the government intends to negotiate with a single source, interested vendors may submit responses to the contracting officer by August 31, 2026, at 4:30pm Eastern Time. The government will use these responses to determine whether to proceed with a sole source award or transition to a competitive procurement process.

Office Of Acquisition

POSTED

DEADLINE

6505--Rubidium Rb-82 Generator and Associated Supplies

Solicitation # 36C26127Q0032

The Department of Veterans Affairs, Network Contracting Office 21, intends to award a sole source delivery order to Bracco Diagnostics Inc. for the procurement of Rubidium Rb-82 generators, infusion system leasing, and associated consumables. This acquisition supports Cardiac PET imaging clinical operations at the VA Northern California Health Care System in Mather, California. The requirement is designated as a sole source because the equipment and elution system components are proprietary to Bracco Diagnostics Inc., the original equipment manufacturer. The scope of work includes the delivery of approximately nine generators per year, a 12-month infusion system lease, and various supplies such as accessory packs, waste bottles, elution test vials, and thermal printer paper to ensure compatibility with existing CardioGen 82 systems. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. To be eligible for participation, vendors must be an OEM, authorized dealer, distributor, or reseller and provide documentation proving such authority. Compliance with VAAR 852.212-71 and VAAR 852.212-72 regarding Gray Market and Counterfeit Items is mandatory. Interested parties must submit a capability statement, proposal, or quotation to the contracting officer by September 9, 2026, at 3:00 pm Pacific Standard Time.

261-NETWORK Contract Office 21 (36C261)

POSTED

DEADLINE

Script Center Relocation

Solicitation # PANDHA26P000046644

The Defense Health Agency is soliciting a combined contract under solicitation number PANDHA26P000046644 for the relocation of script center equipment. The project involves moving various assets across multiple military installations, including the relocation of two units within the Cherry Point Exchange in North Carolina, one unit from the Dyess AFB Exchange to the Dyess AFB Clinic in Texas, one unit and lockers from the Ft. Carson Exchange to the Ft. Carson Hospital in Colorado, and one unit and lockers from the Maxwell AFB Exchange in Alabama to the Walter Reed Exchange in Maryland. This opportunity is categorized under NAICS code 325412 and is open to all bidders as there is no set-aside used. The solicitation was posted on August 27, 2026, with a response deadline of September 10, 2026. Primary coordination for this requirement is managed by Sandra Kharan and Saera Khan out of the agency's office in Falls Church, Virginia.

Defense Health Agency

POSTED

DEADLINE

Dapagliflozin Tablets

Solicitation # SPE2D2-26-R-0018

DLA Troop Support

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

6505--Ticagrelor Tablets

Solicitation # 36E79726R0028

The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--2027-2028 Influenza Virus Vaccine

Solicitation # 36E79726R0035

The VA National Acquisition Center intends to issue Request for Proposal 36E79726R0035 for the procurement of Influenza Virus Vaccines for the 2027-2028 season. This unrestrictive procurement supports the Department of Veterans Affairs, State Veteran Homes option 2, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The requirement covers three specific vaccine presentations: a general dose for persons 36 months and older, a dose specifically for persons 65 years and older, and a pediatric dose for children 6 months to 35 months. Total estimated annual usage across all agencies is approximately 276,559 boxes of 10 syringes. Evaluation and award will be conducted by solicitation line item, and offerors must provide the full quantity for any line item they bid on. Pricing must include the Cost Recovery Fee and Federal Excise Tax, with identical unit pricing required for the same presentation across different line items. Delivery is FOB Destination to facilities in the United States, the Philippines, and Puerto Rico. Most facilities require a split delivery schedule between August 15 and October 15, 2027, while the Captain James A. Lovell Federal Health Care Center must receive its full quantity by September 15, 2027. The solicitation is expected to be issued around September 8, 2026, with a closing date of September 24, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Tacrolimus Capsules

Solicitation # 36E79726R0033

The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement for Tacrolimus Capsules to establish an uninterrupted source of supply for multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded to a single responsible offeror and follows FAR Part 12 commercial item procedures. The period of performance consists of a one-year base period with four pre-priced one-year option periods. Distribution of the pharmaceuticals will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers three capsule strengths with estimated annual quantities of 51,904 bottles of 0.5mg, 142,788 bottles of 1mg, and 5,207 bottles of 5mg, all in package sizes of 100. Strict labeling requirements are in place, requiring the offeror to provide the exact drug name and a unique NDC number belonging to the offeror. The contractor's label must be the only label on the product, and affixing labels over existing labels is strictly prohibited. The solicitation is managed by the Enterprise Procurement Office in Hines, Illinois, with a tentative closing date of September 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Logistics and Distribution via Pharmaceutical Prime Vendor Programs

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Labeling and Over-Label Adhesion Services

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Unit-of-Use Pharmaceutical Bottle Supply

All Other Plastics Product Manufacturing

POSTED

DEADLINE

6505--Lisinopril Tablets (VA-27-00004937)

Solicitation # 36E79726R0032

The Department of Veterans Affairs National Acquisition Center is issuing an unrestricted procurement under solicitation 36E79726R0032 for Lisinopril Tablets to support the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded to a single responsible offeror to ensure an uninterrupted source of supply for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. Offerors must provide a unique NDC number and ensure the product label is the only one on the packaging. Specific packaging requirements for designated unit-of-use bottles include a minimum 120cc volume, a cylindrical body with at least a 5.75 inch circumference, and safety caps that are either convertible or deshellable. The solicitation is expected to be released in commercial item format on September 3, 2026, with a closing date of September 24, 2026. This procurement falls under NAICS code 325412 and all documentation and amendments will be available electronically via SAM.gov.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Packaging, Labeling, and NDC Compliance ServicesThis subcontract with Nac Pharmaceuticals under the Department of Veterans Affairs focuses on the final packaging and labeling of Tacrolimus bottles. The scope of work requires the implementation of a sole-label system and the assignment of a unique National Drug Code to ensure full compliance with federal pharmaceutical labeling regulations. The project is categorized under NAICS code 325991 and was posted on August 13, 2026. The primary objective is to maintain strict regulatory adherence during the bottling process to meet government healthcare standards for pharmaceutical distribution.

Custom Compounding of Purchased Resins

POSTED

DEADLINE

National Distribution and Logistics via Prime Vendor NetworkThis subcontract involves the national distribution and logistics of Tacrolimus bottles to various federal healthcare facilities, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The operations are managed through the VA/DoD Pharmaceutical Prime Vendor Programs to ensure efficient delivery across these networks. The contract is administered by Nac Pharmaceuticals under the Department of Veterans Affairs, utilizing NAICS code 424210 for wholesale distribution of drugs and pharmaceuticals. The agreement focuses on the streamlined supply chain management required to provide critical medication to multiple government agency facilities nationwide.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Manufacturing of Tacrolimus Capsules (0.5mg, 1mg, 5mg)Nac Pharmaceuticals, under the Department of Veterans Affairs, is seeking a subcontractor for the full-scale manufacturing of Tacrolimus Capsules in 0.5mg, 1mg, and 5mg strengths. The scope of work encompasses the entire production lifecycle, including formulation, encapsulation, quality control, and final batch release. All manufacturing activities must be conducted in strict accordance with FDA regulations and current Good Manufacturing Practice standards. This subcontract falls under NAICS code 325412 and was posted on August 13, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE